Yiqing Du

987 total citations
65 papers, 595 citations indexed

About

Yiqing Du is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yiqing Du has authored 65 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Yiqing Du's work include Bladder and Urothelial Cancer Treatments (24 papers), Renal cell carcinoma treatment (10 papers) and Urinary and Genital Oncology Studies (7 papers). Yiqing Du is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Renal cell carcinoma treatment (10 papers) and Urinary and Genital Oncology Studies (7 papers). Yiqing Du collaborates with scholars based in China, United States and Japan. Yiqing Du's co-authors include Tao Xu, Caipeng Qin, Deshu Xu, Xu Chen, Min Lu, Gongwei Wang, Ruoyan Li, Fan Bai, Ziyang Liu and Zhanghua Chen and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yiqing Du

55 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiqing Du China 13 277 127 113 113 109 65 595
Xiangying Xu China 15 282 1.0× 158 1.2× 99 0.9× 147 1.3× 77 0.7× 38 543
Eva Løbner Lund Denmark 15 408 1.5× 212 1.7× 91 0.8× 235 2.1× 83 0.8× 45 753
Xiaoming Hou China 19 382 1.4× 207 1.6× 126 1.1× 175 1.5× 48 0.4× 60 747
Qi Lin China 15 382 1.4× 119 0.9× 82 0.7× 116 1.0× 57 0.5× 70 629
Evelyn Aranda United States 11 412 1.5× 126 1.0× 55 0.5× 210 1.9× 68 0.6× 12 753
Ning Yin China 13 452 1.6× 181 1.4× 97 0.9× 145 1.3× 60 0.6× 44 699
Yunkai Yang China 5 403 1.5× 132 1.0× 84 0.7× 180 1.6× 56 0.5× 8 735
Qiqi Lu China 15 280 1.0× 104 0.8× 48 0.4× 58 0.5× 95 0.9× 39 620
Lianghui Zhang United States 13 482 1.7× 83 0.7× 100 0.9× 57 0.5× 63 0.6× 20 794
Xiao Huang United States 12 393 1.4× 82 0.6× 89 0.8× 119 1.1× 68 0.6× 40 664

Countries citing papers authored by Yiqing Du

Since Specialization
Citations

This map shows the geographic impact of Yiqing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqing Du more than expected).

Fields of papers citing papers by Yiqing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqing Du. The network helps show where Yiqing Du may publish in the future.

Co-authorship network of co-authors of Yiqing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqing Du. A scholar is included among the top collaborators of Yiqing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqing Du. Yiqing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yulong, et al.. (2024). Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 42(9). 266–274. 1 indexed citations
3.
Ding, Mengting, Jiaxing Lin, Yiqing Du, et al.. (2024). Novel CAR‐T Cells Specifically Targeting SIA‐CIgG Demonstrate Effective Antitumor Efficacy in Bladder Cancer. Advanced Science. 11(40). e2400156–e2400156. 9 indexed citations
4.
Du, Yiqing, et al.. (2024). FSH Is Responsible for Androgen Deprivation Therapy–Associated Atherosclerosis in Mice by Exaggerating Endothelial Inflammation and Monocyte Adhesion. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). 698–719. 7 indexed citations
5.
Flores, Jorge, Sean Thompson, Yiqing Du, et al.. (2024). Deep Hair Phenomics: Implications in Endocrinology, Development, and Aging. Journal of Investigative Dermatology. 145(4). 800–811.e8. 2 indexed citations
6.
Han, Sujun, Yining Li, Dong Chen, et al.. (2024). Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort. Clinical Genitourinary Cancer. 23(2). 102280–102280.
7.
Song, Yuxuan, Yun Peng, Jiaxing Lin, et al.. (2024). The role of histological subtype and chemotherapy on prognosis of ureteral cancer. Journal of Cancer Research and Clinical Oncology. 150(4). 192–192. 2 indexed citations
8.
Song, Yuxuan, Caipeng Qin, Yun Peng, et al.. (2023). GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females. Journal of Cancer Research and Clinical Oncology. 149(10). 6827–6840. 2 indexed citations
9.
Li, Jialin, Juwei Mu, Feng Li, et al.. (2023). Silva Classification System for HPV-Related EAC of Stage I ∼ IIIc1p Cervical Adenocarcinoma and Its Effect on Prognosis and Survival. International Journal of Radiation Oncology*Biology*Physics. 117(2). e526–e526. 1 indexed citations
10.
Song, Yuxuan, et al.. (2023). Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1β Contributing to Atherosclerosis Progression. The Journal of Immunology. 210(1). 25–32. 10 indexed citations
11.
12.
Song, Yuxuan, Yun Peng, Caipeng Qin, et al.. (2023). Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. Journal for ImmunoTherapy of Cancer. 11(9). e006643–e006643. 17 indexed citations
13.
Lin, Jiaxing, Mengting Ding, Caipeng Qin, et al.. (2023). A robust gene prognostic index composed of GZMB, IRF1, and TP63 can stratify the risk of two metastatic urothelial carcinoma cohorts based on immune checkpoint blockade therapy. Journal of Cancer Research and Clinical Oncology. 149(12). 9877–9890.
14.
Wang, Fei, Yiqing Du, Caipeng Qin, et al.. (2022). Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center. Frontiers in Oncology. 12. 816915–816915. 1 indexed citations
15.
16.
Du, Yiqing, Wenbo Yang, Huixin Liu, et al.. (2021). Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 20(1). e75–e80. 11 indexed citations
17.
Li, Ruoyan, Yiqing Du, Zhanghua Chen, et al.. (2020). Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science. 370(6512). 82–89. 115 indexed citations
18.
Liu, Chunlei, Lili Chen, Xiaowei Zhang, et al.. (2017). The evaluation of health-related quality of life for prostate cancer patients receiving androgen deprivation therapy. Zhonghua miniao waike zazhi. 38(1). 33–37.
19.
Guan, Zhenfeng, Chen Ding, Yiqing Du, et al.. (2013). HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells. International Journal of Oncology. 44(2). 393–402. 34 indexed citations
20.
Xu, Xiaofei, Kun Li, Shuhong Zhao, et al.. (2008). Molecular characterization, expression and association analysis of the porcine CMYA4 gene with carcass traits. Journal of Animal Breeding and Genetics. 125(4). 234–239. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangying Xu Breakdown of academic impact, for papers by Eva Løbner Lund Breakdown of academic impact, for papers by Xiaoming Hou Breakdown of academic impact, for papers by Qi Lin Breakdown of academic impact, for papers by Evelyn Aranda Breakdown of academic impact, for papers by Ning Yin Breakdown of academic impact, for papers by Yunkai Yang Breakdown of academic impact, for papers by Qiqi Lu Breakdown of academic impact, for papers by Lianghui Zhang Breakdown of academic impact, for papers by Xiao Huang
Rankless by CCL
2026